The settlement resolves allegations the company engaged in several practices that resulted in the submission of false claims to Medicare and Medicaid.
The government alleged Signature placed patients in the highest therapy reimbursement level without performing individualized evaluations to determine the level of care most appropriate for each patient. The government further alleged Signature pressured therapists and patients to complete the minimum number of minutes of therapy required to bill at a given reimbursement level, even when patients were sick or declined to participate in the therapy.
The allegations against Signature were originally brought by two former employees in a lawsuit filed under the qui tam, or whistle-blower, provisions of the False Claims Act.
More articles on legal and regulatory issues:
Blue Cross accuses North Carolina hospital of overbilling by $76M
11 latest healthcare industry lawsuits, settlements
DOJ won’t defend ACA, argues individual mandate is unconstitutional
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
